Review of Interventional Late Breaking Trials From AHA Scientific Sessions 2020 Virtual Meeting.

Authors :: Medranda GA
Case BC
Wermers JP
Morrison N
Yerasi C
Forrestal BJ
Chezar-Azerrad C
Waksman R
Source :: Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2021 Aug; Vol. 29, pp. 71-76. Date of Electronic Publication: 2021 Mar 01.
Publication Year :: 2021
Abstract: Competing Interests: Declaration of competing interest Ron Waksman – Advisory Board: Amgen, Boston Scientific, Cardioset, Cardiovascular Systems Inc., Medtronic, Philips, Pi-Cardia Ltd.; Consultant: Amgen, Biotronik, Boston Scientific, Cardioset, Cardiovascular Systems Inc., Medtronic, Philips, Pi-Cardia Ltd.; Grant Support: AstraZeneca, Biotronik, Boston Scientific, Chiesi; Speakers Bureau: AstraZeneca, Chiesi; Investor: MedAlliance. All other authors – None.

Subjects :: Humans
Research Design
Cardiology
Cardiovascular Diseases diagnosis
Cardiovascular Diseases therapy

Language :: English
ISSN :: 1878-0938
Volume :: 29
Database :: MEDLINE
Journal :: Cardiovascular revascularization medicine : including molecular interventions
Publication Type :: Academic Journal
Accession number :: 34049820
Full Text :: https://doi.org/10.1016/j.carrev.2021.02.020

Full Text Access

Tools